Micah Anderson
Algemeen Directeur bij LEEF BRANDS INC.
Vermogen: 2 M $ op 30-04-2024
Actieve functies van Micah Anderson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| LEEF BRANDS INC. | Directeur/Bestuurslid | 06-09-2022 | - |
| Algemeen Directeur | 06-09-2022 | - | |
Leef Holdings, Inc.
 Leef Holdings, Inc. Agricultural Commodities/MillingProcess Industries Leef Holdings, Inc. provides investment services. The company was founded in 2019 and is headquartered in La Jolla, CA. | Algemeen Directeur | - | - |
| Voorzitter | - | - | |
| Oprichter | - | - | |
Aya Biosciences, Inc.
 Aya Biosciences, Inc. BiotechnologyHealth Technology Aya Biosciences, Inc. is a neuroscience company that is dedicated to improving the mental health and well-being of patients with neuropsychiatric diseases. The company is based in La Jolla, CA. The company is creating a pipeline of novel, orally active serotonin receptor agonists as a new class of therapeutics. The CEO of the company is Micah Anderson. | Directeur/Bestuurslid | - | - |
| Algemeen Directeur | - | - |
Loopbaan van Micah Anderson
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Canada | 2 |
Operationeel
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| Chairman | 1 |
Sectoraal
| Process Industries | 3 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LEEF BRANDS INC. | Process Industries |
| Bedrijven in privébezit | 2 |
|---|---|
Leef Holdings, Inc.
Leef Holdings, Inc. Agricultural Commodities/MillingProcess Industries Leef Holdings, Inc. provides investment services. The company was founded in 2019 and is headquartered in La Jolla, CA. | Process Industries |
Aya Biosciences, Inc.
Aya Biosciences, Inc. BiotechnologyHealth Technology Aya Biosciences, Inc. is a neuroscience company that is dedicated to improving the mental health and well-being of patients with neuropsychiatric diseases. The company is based in La Jolla, CA. The company is creating a pipeline of novel, orally active serotonin receptor agonists as a new class of therapeutics. The CEO of the company is Micah Anderson. | Health Technology |
- Beurs
- Insiders
- Micah Anderson
- Ervaring
